Perspective Therapeutics (AMEX:CATX) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.26) by 15.38 percent. This is a 26.67 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $81.000 thousand which missed the analyst consensus estimate of $83.154 thousand by 2.59 percent. This is a 72.07 percent decrease over sales of $290.000 thousand the same period last year.